Juris Bundulis
Juris Bundulis is the Chairman of the Board of Olpha, a pharmaceutical company focused on developing and registering new generic medications. He emphasizes the importance of local pharmaceutical production in enhancing price competition and improving patient access to healthcare.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Latvia | 1 | 9.00 | 0.12% | +0% | 1,886,198 | 2,181 | $34,000 | 39$ |
| Totals | 1 | 1,886,198 | 2,181 | $34,000 | 39$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Latvia:
Juris Bundulis expresses happiness that clean, fresh drinking water will now be available in two locations in Olaine for children and youth.
9
Latvia:
Juris Bundulis emphasizes the importance of supporting local manufacturers to strengthen the economy and improve public welfare.
9
Latvia:
Juris Bundulis is the chairman of the board of 'Olpha'.
8
Latvia:
Juris Bundulis, the chairman of the board of Olpha, indicates that each new local company's patent-free medication creates price competition and increases patient accessibility.
8